Form 4 Filing for ACADIA PHARMACEUTICALS INC

This filing details stock transactions by director Elizabeth A. Garofalo on May 29, 2026. She acquired 8,107 shares of Common Stock. Additionally, she was granted 16,004 Director Stock Options with a vesting period over one year and 9,311 Restricted Stock Units that will vest in full on the earlier of one year from the grant date or the next annual stockholder meeting. The filing also notes the disposal of 8,107 Restricted Stock Units which vested on the same day. Ms. Garofalo acquired a total of 8,107 shares and was granted options and RSUs totaling 25,315 shares. Her post-transaction holdings include 33,489 shares of Common Stock, 16,004 vested Director Stock Options, and 9,311 vested Restricted Stock Units.